Related Experiment Videos
[Pharmaco-angiography with angiotensin (author's transl)]
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|April 1, 1976
Summary
Pharmacoangiography with angiotensin enhances diagnostic accuracy in vascular imaging. This technique proves valuable for clarifying uncertain angiographic diagnoses, especially when superselective catheterization is not feasible.
Area of Science:
- Vascular imaging
- Interventional radiology
- Diagnostic angiography
Background:
- Selective angiography is a key diagnostic tool.
- Limitations exist in visualizing certain vascular structures and pathologies.
- Pharmacoangiography offers potential for improved diagnostic yield.
Purpose of the Study:
- To evaluate the efficacy of angiotensin pharmacoangiography.
- To compare its diagnostic performance against standard selective angiography.
- To assess its utility in specific clinical scenarios.
Main Methods:
- Pharmacoangiography using angiotensin was performed in 101 patients.
- Angiography targeted kidneys, pancreas, liver, and peripheral soft tissues.
- Doses of angiotensin varied based on the targeted arterial system.
Main Results:
- Angiotensin demonstrated potent vasoconstriction in 99% of cases.
- Improved diagnostic evaluation occurred in 66-77% of cases with tumors, cysts, and inflammatory processes.
- Angiographic diagnosis was solely possible via pharmacoangiography in 11% of cases.
Conclusions:
- Angiotensin pharmacoangiography is a valuable adjunct to selective angiography.
- It significantly improves the clarification of uncertain angiographic diagnoses.
- This technique is particularly useful when superselective catheterization is challenging.